Scott Bizily - Jun 1, 2023 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Chief Legal and HR Officer
Signature
/s/ August Moretti as Attorney-in-fact for Scott Bizily
Stock symbol
FDMT
Transactions as of
Jun 1, 2023
Transactions value $
-$28,974
Form type
4
Date filed
6/6/2023, 07:23 PM
Previous filing
Apr 25, 2023
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Options Exercise $12.2K +1.88K +88.9% $6.49 3.98K Jun 1, 2023 Direct F1
transaction FDMT Common Stock Sale -$41.1K -2.25K -56.4% $18.31 1.74K Jun 1, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Options Exercise $0 -1.88K -9.26% $0.00 18.4K Jun 1, 2023 Common Stock 1.88K $6.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person intended to comply with the prior version of rule 10b5-1.
F2 The transaction was executed in multiple trades in prices ranging from $17.95 to $18.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.